Haiqing Yuan,John E. Donello,Richard L. Beard,Tien T. Duong,Xiaoxia Liu
申请号：
BRPI0821977
公开号：
BRPI0821977A2
申请日:
2008.07.10
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The invention provides compounds represented by the formula I, each of which compounds may have sphingosine-1-phosphate receptor agonist and/or antagonist biological activity: and wherein the variables Y, R<；SUP>；4<；/SUP>；, n, o, A, A<；SUP>；1<；/SUP>；, A<；SUP>；2<；/SUP>；, X, Z, R<；SUP>；1<；/SUP>；, R<；SUP>；3<；/SUP>；, R<；SUP>；2<；/SUP>；, p, q and r are as defined in the specification. These compounds are useful for treating a disease or condition selected from the group consisting of glaucoma, dry eye, angiogenesis, cardiovascular conditions and diseases, and wound healing
